COVID-19 associated myopathy with severe proximal and bulbar weakness is characterized by elevated levels of IL-6 and Creatine PhosphoKinase (CPK) and the histological features of COVID-19 are mostly anecdotic and only a few case reports have been recently published on this subject. The gene discussed is PIK3C2A; the disease is COVID-19.